Hampton Roads Oncology Update 2019:

Transcription

1 Hampton Roads Oncology Update 2019: New Advances in Gastrointestinal Cancers SATURDAY, JULY 27, :00 AM 1:45 PM Marriott at City Center Newport News, Virginia 5 AMA PRA Category 1 Credits EVMS Eastern Virginia Medical School

2 Hampton Roads Oncology Update 2019: New Advances in Gastrointestinal Cancers There has been significant progress in the treatment of gastrointestinal cancers. Learning more about the available clinical data is of the upmost importance when providing the best care to patients with gastrointestinal cancers. This conference will help educate community health care professionals. This program is designated for up to 5 AMA PRA Category 1 Credits This conference is designed for oncologists, primary care physicians, pathologists, surgeons, gastroenterologists, pharmacists, physician assistants, nurse practitioners, and other interested health care professionals. COURSE DIRECTORS: David Z. Chang, MD, PhD, FACP Director, GI Oncology, Virginia Oncology Associates Associate Professor of Internal Medicine, EVMS Bo Zhao, MD, PhD Clinical Assistant Professor Case Western Reserve University UH Seidman Cancer Center SCIENTIFIC COMMITTEE: Scott Kruger, MD Virginia Oncology Associates Assistant Professor of Clinical Internal Medicine, Department of Internal Medicine, EVMS Jane Liu, MD, MS Physician Director of Medical Informatics Illinois Cancer Care Lei Zheng, MD, PhD Associate Professor of Oncology and Surgery Gastrointestinal Cancer Program Tumor Immunology Program Graduate Program in Cellular & Molecular Medicine Johns Hopkins University School of Medicine FACULTY: Ghassan Abou-Alfa, MD Attending Physician, Memorial Sloan Kettering Cancer Center Basem Azab, MD Surgical Oncology, Sentara Cancer Network Assistant Professor, Department of Surgery, EVMS David Z. Chang, MD, PhD, FACP Director, GI Oncology, Virginia Oncology Associates Associate Professor of Internal Medicine, EVMS Shuang Fu, MD, PhD Medical Oncology, Kirkland Cancer Center Andrea Wang Gillam, MD, PhD Associate Professor Director, Developmental Therapeutics Program Clinical Director, GI Oncology Program, Alvin J. Siteman Cancer Center Ping Gu, MD, PhD Assistant Attending Physician GI Medical Oncology Memorial Sloan Kettering Cancer Center Jin He, MD, PhD Associate Professor Surgical Oncology, Johns Hopkins Medical Center Yuxia Jia, MD Medical Oncology Chinese American Hematologist/Oncologist Network (CAHON) Song Kang, MD Radiation Oncology Virginia Oncology Associates Feng-Ming (Spring) Kong, MD, PhD, FACR Professor, Radiation Oncology, Case Western Reserve University Jonathan Lee, MD, MS University of Illinois at Chicago Tifany Lewis, MS, CGC Manager of Genetic Counseling Virginia Oncology Associates Edward Lin, MD Associate Professor, Medicine University of Washington School of Medicine Eileen M. O Reilly, MD Section Head Hepatopancreaticobiliary/ Neuroendocrine Cancers Associate Director, David M. Rubenstein Center for Pancreatic Cancer Attending Physician, Member, Memorial Sloan Kettering Cancer Center Weill Cornell Medical College Weijing Sun, MD, FACP The Sprint Professor of Medical Oncology Director, Division of Medical Oncology University of Kansas Medical Center Associate Director, University of Kansas Cancer Center Jiping Wang, MD, PhD Assistant Professor of Surgery Dana Farber Cancer Center Harvard Medical School Xuejun Zhao, MD Associate Chief Physician Shandong Provincial Hospital Lei Zheng, MD, PhD Associate Professor of Oncology and Surgery Gastrointestinal Cancer Program Tumor Immunology Program Graduate Program in Cellular & Molecular Medicine Johns Hopkins University School of Medicine Andrew X. Zhu, MD, PhD, FACP Professor of Medicine Harvard Medical School Director, Liver Cancer Research Massachusetts General Hospital Cancer Center

3 CONFERENCE AGENDA 7:00 AM 08:00 AM Registration & Breakfast 8:00 AM 08:05 AM Welcome and Introduction Speaker: David Z. Chang, MD, PhD, FACP 8:05 AM 08:25 AM Updates on Esophageal Cancer Speaker: Weijing Sun, MD, FACP 8:25 AM 08:45 AM New Concepts in Treatments of Gastric Cancer Speaker: Jiping Wang, MD, PhD 8:45 AM 09:05 AM Cholangiocarcinoma: What Is the Current Standard? Speaker: Ghassan Abou-Alfa, MD 9:05 AM 09:25 AM Liver Cancer: Now More Options but How to Best Sequence Them? Speaker: Andrew Zhu, MD, PhD, FACP 9:25 AM 09:45 AM Pancreatic Cancer: Where Are We in 2019? Speaker: Eileen O Reilly, MD 9:45 AM 10:05 AM Surgical Pearls of Pancreatectomy Among Pancreas Cancer Patients in Neoadjuvant Therapy Era Speaker: Basem Azab, MD 10:05 AM 10:25 AM Break & Exhibit Visits 10:25 AM 10:45 AM Neuroendocrine Tumor: What is the Current State-of-Art Treatment Approaches? Speaker: Andrea Wang Gillam, MD, PhD 10:45 AM 11:05 AM Sidedness of Colon Cancer: Implications on Prognosis and Choice of Systemic Therapy Speaker: David Z. Chang, MD, PhD, FACP 11:05 AM 11:25 AM Adjuvant Therapy for Colon Cancer: 3 or 6 months? Speaker: Edward Lin, MD, FACP 11:25 AM 11:45 AM Immunotherapy for GI Cancers Speaker: Lei Zheng, MD, PhD, FACP 11:45 AM 12:05 PM Non-medical Management for Advanced Cancer Pain Speaker: Xuejun Zhao, MD 12:05 PM 12:25 PM Role of Genetic Counselor in Cancer Care Speaker: Tifany Lewis, MS, CGC 12:25 PM 12:45 PM Exhibitor Time & Lunch 12:45 PM 1:45 PM Lunch Session: Case Discussions Case 1: Resectable Pancreatic Cancer (Dr. Jonathan Lee) Case 2: Colon Cancer with Resectable Liver Mets (Dr. Shuang Fu) Panelists: 1:45 PM Adjourn Basem Azab, MD (Surg Onc) Jin He, MD, PhD (Surg Onc) Yuxia Jia, MD (Med Onc) Ping Gu, MD, PhD (Med Onc) Song Kang, MD (Rad Onc) Spring Kong, MD, PhD (Rad Onc) Speaker: David Z. Chang, MD, PhD, FACP

4 LEARNING OBJECTIVES: Identify state-of-the-art management of GI cancers including esophageal cancer, gastric cancer, pancreatic cancer, liver cancer, cholangiocarcinoma, and colon cancer. Explain the advances in immunotherapy in GI cancers. Summarize the multimodality managements of resectable pancreatic cancer and rectal cancer with liver metastases. ACCREDITATION This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Eastern Virginia Medical School and Virginia Oncology Associates. Eastern Virginia Medical School is accredited by the ACCME to provide continuing medical education for physicians. CREDIT DESIGNATION Eastern Virginia Medical School designates this live activity for a maximum of 5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. SPECIAL SERVICES The American with Disabilities Act of 1990 requires that all individuals, regardless of the disability, have equal access. If special arrangements are required to attend this conference, contact the Office of Continuing Medical Education at

5 Newport News Marriott at City Center 740 Town Center Drive Newport News, Virginia REGISTRATION INFORMATION New Advances in Gastrointestinal Cancers MARRIOTT AT CITY CENTER NEWPORT NEWS, VIRGINIA SATURDAY, JULY 27, :00 AM 1:45 PM PLEASE PRINT OR TYPE NAME DEGREE REGISTRATION FEE: $65 FOR ALL PARTICIPANTS. SSN (LAST FOUR DIGITS ONLY) SPECIALTY ONLINE: REGISTER ONLINE AT CREDIT CARD ONLY (VISA, MASTERCARD OR DISCOVER) MAILING ADDRESS CITY STATE ZIP BY MAIL: MAIL YOUR COMPLETED FORM AND CHECK PAYABLE TO EVMS-CME TO: 358 Mowbray Arch, Suite 207 Norfolk, VA REGISTRATION DEADLINE: FRIDAY, JULY 19, 2019 TELEPHONE FAX (ELECTRONIC CONFIRMATION & FOLLOW-UP) EVMS-CME USE ONLY DATE REVISED: DATE ENTERED: CONFIRMATION:

6 5900 Lake Wright Drive, Ste. 300 Norfolk, VA Non-Profit Org. U.S. Postage PAID Norfolk, VA Permit No. 22